1. Home
  2. PHVS vs MCBS Comparison

PHVS vs MCBS Comparison

Compare PHVS & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • MCBS
  • Stock Information
  • Founded
  • PHVS 2015
  • MCBS 2006
  • Country
  • PHVS Netherlands
  • MCBS United States
  • Employees
  • PHVS N/A
  • MCBS N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • MCBS Major Banks
  • Sector
  • PHVS Health Care
  • MCBS Finance
  • Exchange
  • PHVS Nasdaq
  • MCBS Nasdaq
  • Market Cap
  • PHVS 1.0B
  • MCBS 863.1M
  • IPO Year
  • PHVS 2021
  • MCBS 2019
  • Fundamental
  • Price
  • PHVS $19.18
  • MCBS $32.80
  • Analyst Decision
  • PHVS Strong Buy
  • MCBS Hold
  • Analyst Count
  • PHVS 5
  • MCBS 1
  • Target Price
  • PHVS $40.60
  • MCBS $36.00
  • AVG Volume (30 Days)
  • PHVS 97.7K
  • MCBS 42.6K
  • Earning Date
  • PHVS 11-13-2024
  • MCBS 01-21-2025
  • Dividend Yield
  • PHVS N/A
  • MCBS 2.83%
  • EPS Growth
  • PHVS N/A
  • MCBS 17.79
  • EPS
  • PHVS N/A
  • MCBS 2.33
  • Revenue
  • PHVS N/A
  • MCBS $135,566,000.00
  • Revenue This Year
  • PHVS N/A
  • MCBS N/A
  • Revenue Next Year
  • PHVS N/A
  • MCBS $3.39
  • P/E Ratio
  • PHVS N/A
  • MCBS $13.97
  • Revenue Growth
  • PHVS N/A
  • MCBS 11.66
  • 52 Week Low
  • PHVS $15.37
  • MCBS $21.89
  • 52 Week High
  • PHVS $33.00
  • MCBS $36.15
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 46.34
  • MCBS 45.74
  • Support Level
  • PHVS $18.32
  • MCBS $31.57
  • Resistance Level
  • PHVS $20.00
  • MCBS $35.00
  • Average True Range (ATR)
  • PHVS 1.10
  • MCBS 1.19
  • MACD
  • PHVS 0.11
  • MCBS -0.25
  • Stochastic Oscillator
  • PHVS 51.13
  • MCBS 31.71

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

Share on Social Networks: